Have you ever taken a chance on a start up before? The intellectual property alone of this company in my opinion is easily worth $1B and if things work out without too many more glitches UNXL will prove my point within the next year or two.
Have you ever invested in biopharma before?
Take Galena pharmaceuticals for example. Here is another company with intellectual property worth maybe $1B or more. Basically, they have zero revenues and get the money they need to fund phase III trials of their product Neuvax by diluting shares every couple of months. I have no doubt that Neuvax will be approved for breast cancer in 2016. However, shares will be diluted to the point where this stock will be lucky to break $10/share. To me that is overvalued.
Sentiment: Strong Buy